Blacksburg, VA, United States of America

Michael Mendicino


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Michael Mendicino

Introduction

Michael Mendicino is an accomplished inventor based in Blacksburg, Virginia. He has made significant contributions to the field of biomedical research, particularly in the development of immunocompromised ungulates. His work focuses on creating porcine animals that serve as valuable models for pharmaceutical and biological research.

Latest Patents

Mendicino holds a patent for his innovative work titled "Immunocompromised ungulates." This patent describes porcine animals, tissues, and organs that lack functional endogenous immunoglobulin loci, resulting in a deficiency in immunoglobulin expression and B-cells. These specially designed animals are instrumental for research and the development of new pharmaceutical agents. Additionally, the patent outlines methods for preparing such animals.

Career Highlights

Michael Mendicino is currently employed at Revivicor, Inc., a company dedicated to advancing regenerative medicine and biotechnology. His role at Revivicor allows him to apply his expertise in creating genetically modified animals for research purposes. His innovative approach has positioned him as a key figure in the field.

Collaborations

Mendicino collaborates with notable colleagues, including David Ayares and Kevin Wells. Their combined efforts contribute to the advancement of research in immunology and regenerative medicine.

Conclusion

Michael Mendicino's work exemplifies the intersection of innovation and biomedical research. His contributions to the development of immunocompromised ungulates have the potential to revolutionize the way researchers study diseases and develop new treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…